{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:46:29Z","timestamp":1790786789358,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.eururo.2018.07.024","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T23:09:27Z","timestamp":1533164967000},"page":"585-594","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies"],"prefix":"10.1016","volume":"74","author":[{"given":"Eleanor L.","family":"Watts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul N.","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Perez-Cornago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bas","family":"Bueno-de-Mesquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Flicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal D.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham G.","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Giovannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi E.","family":"Gislefoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J.","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knekt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence N.","family":"Kolonel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Le Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Luben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapio","family":"Luostarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"M\u00e4nnist\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jeffrey","family":"Metter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Ozasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Platz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Ram\u00f3n","family":"Quir\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harri","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Stampfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank Z.","family":"Stanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4r","family":"Stattin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Tamakoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Tangen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos K.","family":"Tsilidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Tsugane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giske","family":"Ursin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Vatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu B.","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi E.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth C.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2018.07.024_bib0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.eururo.2018.07.024_bib0215","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1215932","article-title":"Long-term survival of participants in the Prostate Cancer Prevention Trial","volume":"369","author":"Thompson","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2018.07.024_bib0220","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2018.07.024_bib0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2018.07.024_bib0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/humu.22909","article-title":"Putative prostate cancer risk SNP in an androgen receptor-binding site of the melanophilin gene illustrates enrichment of risk SNPs in androgen receptor target sites","volume":"37","author":"Bu","year":"2016","journal-title":"Hum Mutat"},{"key":"10.1016\/j.eururo.2018.07.024_bib0235","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.91","article-title":"Multiple loci identified in a genome-wide association study of prostate cancer","volume":"40","author":"Thomas","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2018.07.024_bib0240","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pros.2990030605","article-title":"Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone","volume":"3","author":"Pollard","year":"1982","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2018.07.024_bib0245","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1210\/en.2014-1688","article-title":"Testosterone treatment is a potent tumor promoter for the rat prostate","volume":"155","author":"Bosland","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.eururo.2018.07.024_bib0250","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2018.07.024_bib0255","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/er.2016-1067","article-title":"Dihydrotestosterone: biochemistry, physiology, and clinical Implications of elevated blood levels","volume":"38","author":"Swerdloff","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eururo.2018.07.024_bib0260","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2008.09.024","article-title":"Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth","volume":"55","author":"Morgentaler","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.07.024_bib0265","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0022-5347(17)41083-4","article-title":"The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia","volume":"141","author":"Weber","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.07.024_bib0270","first-page":"S31","article-title":"Comparison of clinical trials with finasteride and dutasteride","volume":"6","author":"Nickel","year":"2004","journal-title":"Rev Urol"},{"key":"10.1016\/j.eururo.2018.07.024_bib0275","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone's binding in circulation: physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eururo.2018.07.024_bib0280","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0378-5122(80)90044-4","article-title":"Interrelationships between sex hormone-binding globulin and testosterone, 5 alpha-dihydrotestosterone and oestradiol-17 beta in blood of normal men","volume":"2","author":"Bartsch","year":"1980","journal-title":"Maturitas"},{"key":"10.1016\/j.eururo.2018.07.024_bib0285","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2018.07.024_bib0290","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/1055-9965.EPI-10-0061","article-title":"Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones","volume":"19","author":"Key","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.07.024_bib0295","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/sim.4780100703","article-title":"Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group","volume":"10","author":"Easton","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.eururo.2018.07.024_bib0300","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/sim.1485","article-title":"Improved estimates of floating absolute risk","volume":"23","author":"Plummer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.eururo.2018.07.024_bib0305","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.eururo.2012.05.025","article-title":"Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events Trial","volume":"62","author":"Muller","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2018.07.024_bib0310","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1023\/A:1008805718310","article-title":"The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States","volume":"9","author":"Legler","year":"1998","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.eururo.2018.07.024_bib0315","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jcb.20228","article-title":"Prostate specific antigen gene regulation by androgen receptor","volume":"93","author":"Kim","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.eururo.2018.07.024_bib0320","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1158\/1055-9965.EPI-04-0371","article-title":"Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era","volume":"14","author":"Platz","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.07.024_bib0325","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pros.1046","article-title":"High-grade prostate cancer is associated with low serum testosterone levels","volume":"47","author":"Schatzl","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2018.07.024_bib0330","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0022-5347(05)67812-3","article-title":"Is low serum free testosterone a marker for high grade prostate cancer?","volume":"163","author":"Hoffman","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2018.07.024_bib0335","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5152\/tud.2017.35467","article-title":"Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial","volume":"43","author":"Bayar","year":"2017","journal-title":"Turk J Urol"},{"key":"10.1016\/j.eururo.2018.07.024_bib0340","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1464-410X.2011.10652.x","article-title":"Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer","volume":"109","author":"Sluis TMvd","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2018.07.024_bib0345","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1158\/0008-5472.CAN-13-0427","article-title":"Gleason grade progression is uncommon","volume":"73","author":"Penney","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.eururo.2018.07.024_bib0350","doi-asserted-by":"crossref","first-page":"12679","DOI":"10.1073\/pnas.0704940104","article-title":"Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor","volume":"104","author":"Wu","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.eururo.2018.07.024_bib0355","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/edrv-8-3-338","article-title":"The endocrinology and developmental biology of the prostate","volume":"8","author":"Cunha","year":"1987","journal-title":"Endocr Rev"},{"key":"10.1016\/j.eururo.2018.07.024_bib0360","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.ejca.2007.09.022","article-title":"Prostate volume and adverse prostate cancer features: fact not artifact","volume":"43","author":"Briganti","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2018.07.024_bib0365","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/jnci\/djm130","article-title":"Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial","volume":"99","author":"Cohen","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2018.07.024_bib0370","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djm117","article-title":"Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial","volume":"99","author":"Lucia","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2018.07.024_bib0375","first-page":"22","article-title":"Histopathological effects of androgen deprivation in prostatic cancer","volume":"14","author":"Civantos","year":"1996","journal-title":"Semin Urol Oncol"},{"key":"10.1016\/j.eururo.2018.07.024_bib0380","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-4295(97)00164-7","article-title":"Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy","volume":"49","author":"Reuter","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2018.07.024_bib0385","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djj307","article-title":"Effect of finasteride on the sensitivity of PSA for detecting prostate cancer","volume":"98","author":"Thompson","year":"2006","journal-title":"JNCI"},{"key":"10.1016\/j.eururo.2018.07.024_bib0395","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1210\/jc.2013-3375","article-title":"Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism","volume":"98","author":"Handelsman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2018.07.024_bib0400","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1210\/jc.2003-031287","article-title":"Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry","volume":"89","author":"Wang","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eururo.2018.07.024_bib0405","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1158\/1055-9965.EPI-06-0792","article-title":"Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry","volume":"16","author":"Hsing","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.eururo.2018.07.024_bib0410","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/jcem.74.4.1548361","article-title":"Representativeness of a single point plasma testosterone level for the long term hormonal milieu in men","volume":"74","author":"Vermeulen","year":"1992","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818305463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283818305463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T13:49:00Z","timestamp":1717249740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283818305463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0302283818305463"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2018.07.024","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2018.07.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}